Treatment of High Blood Pressure Using Olmesartan With Hydrochlorothiazide Compared to an ACE Inhibitor With a Calcium Channel Blocker

Daiichi Sankyo

Status and phase: Completed; Phase 4

Conditions: Hypertension

Treatments: Drug: Olmesartan medoxomil; Drug: Benazepril; Drug: Amlodipine; Drug: Hydroclorothiazide

Study type: Interventional

Funder types: Industry

Identifiers

NCT00185120

866-447

Details and patient eligibility

About

A comparison of 2 different combinations of high blood pressure medications to treat hypertension

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Greater than 18 years of age
• Patients with high blood pressure

Exclusion criteria

• Hypertensive encephalopathy, stroke or transient ischemic attack within the past 6 months
• History of myocardial infarction, percutaneous transluminal coronary revascularization, coronary artery bypass graft, and/or unstable angina pectoris within the past 6 months
• Type 1 diabetes mellitus

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind